FORMULATION COMPRISING GEFITINIB AS ORAL SUSPENSION

摘要

A pharmaceutical suspension suitable for oral administration containing an effective amount of gefitinib to improve palatability, ensuring adequate therapeutic levels of drug concentration, in comparison to the commercial tablet dosage form and thus patient compliance can be achieved. The invention also relates to a process for the preparation of stable aqueous oral formulation that can be swallowed easily and comprising active ingredient in an effective concentration for the better therapy especially for the monotherapy for the continued treatment of patients with locally advanced or metastatic non-small cell lung cancer or unresectable head and neck cancer.